September 10th, 2020 | 07:37 CEST
Allianz, Bayer, Newlox - Opportunities and risks go hand in hand
Table of contents:
"[...] The transaction offers benefits to all parties: Shareholders now have three promising projects in their portfolio. [...]" Bradley Rourke, President, CEO and Director, Scottie Resources Corp.
Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders.
Gold through environmental remediation
Central banks around the world print money and drive the price of gold to historical levels. While the reserves of the largest gold producers have fallen by 34% since 2012, there are companies that specialize in extracting gold from mining tailings.
Put simply, Newlox Gold Ventures produces gold through environmental remediation. The company is focused on recovering precious metal residues from tailings piles of historical workings in Latin America. These gold-bearing tailings usually date from a time when mining was not yet efficient and rather pragmatic. The company's new environmentally friendly process has already secured access to gold projects in Costa Rica.
Newlox Gold claims that it is well positioned to rapidly scaling up gold production. The revenues are expected to be reinvested in growth, with an initial focus on expansion in other regions of Latin America. Newlox Gold's approach eliminates the conventional, time- and capital-intensive process of permitting, exploration and subsequent mining of gold. Experts now expect that discoveries in 2020 will not go into production for up to 30 years. Newlox Gold does not have this time problem and therefore the scalable business model with the current valuation of around EUR 10 million is an interesting alternative.
Moral and contractual obligations
The German insurance industry is in a tight spot. In recent years, the partners for planning security have concluded various products with their corporate customers, which are intended to provide financial protection in the event of a company closure. Due to the Corona restrictions, which have been in force nationwide since March 2020, a large number of companies, mainly in the catering and tourism industry, have ceased operations.
From the customer's point of view, the insured event has occurred and accordingly, claims will be asserted against the insurance companies. Originally, the insurers assumed that the risk would be manageable, but due to the dimension of the ordered impairments, a damage sum of several billion EUR is rolling towards the companies. Currently, the insurers are still trying to avoid the costs and are trying to find out-of-court solutions with the affected parties. However, the judges at the Regional Court in Munich have already expressed in one case that it does not matter to the affected party how many other policyholders are still affected.
Exciting times are approaching for the insurance giants. Allianz has achieved an operating profit of EUR 4.9 billion in the first half of 2020 and will certainly survive this affair. UBS analysts estimate that the insurance industry could face losses of up to USD 22 billion in connection with business closure insurance - the USA is not included in this estimate.
A 100% chance?
The analysts of the major Swiss bank UBS have a high opinion of the German pharmaceutical and agricultural group. According to the experts' assessment, the share has a potential of EUR 110.00. Up-to-date with approximately EUR 55.00 the shares change their owners and in this context the estimate with doubling potential sounds tempting.
The earnings per share in the first six months of the current fiscal year, which exceeded expectations, were probably the decisive factor in this assessment. For the year as a whole, earnings per share of EUR 6.27 are expected, which according to estimates will rise to EUR 8.34 by 2024. Until confidence in the prospects and euphoria for the company is established, the takeover of the U.S. company Monsanto must also be legally digested. There is no other way to explain the current shyness for Bayer stock.
Conflict of interest
Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.
Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.
Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.
The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.